Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54) and PBM reform including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Duration: November 1, 2013
to
present
General Issues: Health Issues , Medicare/Medicaid , Food Industry (Safety, Labeling, etc.)
Spending: about $2,210,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jim McCrery Former Member of Congress, Louisiana 4th
Ranking Member, House Ways and Means Committee
Committee Member, Joint Committee on Taxation
Aaron K. Cohen Chief of Staff & Leg Asst., Sen. John Ensign
Legislative Aide, Sen. Richard Bryan
Legislative Corresp., Sen. Richard Bryan
Kyle W. Nevins Deputy Chief of Staff, House Majority Leader
Floor Director, Rep. Eric Cantor & Rep. Roy Blunt
Floor Assistant, Rep. Roy Blunt
Drew Goesl Chief of Staff, Rep. Mike Ross
Communications Dir., Sen. Blanche Lincoln
Communicatons Dir., Sen. Blanche Lincoln
Luke Hatzis LD & LA, Cong. Peter Roskam
Republican Clerk, House Rules Committee
Legislative Aide, House Republican Conference
Floor Assistant, Speaker J. Dennis Hastert
C. Towner French Staff, House Committee on Rules; Chief of Staff, Rep. Pete Sessions; Staff, House Committee on Homeland Security; Staff, Rep. Lincoln Diaz-Balart; Staff, Rep. Judy Biggert
Dena Battle Legislative Director, Rep. Dave Camp
Legislative Director, Rep. Nick Smith
Brad Mollet Staff & Research Assistant, Sen. Tim Johnson
Legislative Assistant, Cong. Jim Matheson
Legislative Director, Congw. Betsy Markey
Staff & Research Assistant, Sen. Tim Johnson; Legislative Assistant, Rep. Jim Matheson; Legislative Director, Rep. Betsy Markey.
Jim Gottlieb Chief of Staff, Sen. John D. Rockefeller IV
Staff Director, Senate Veterans Committee
Staff Dir./Gen. Counsel, House Gov Ops Cmte
Robert Diamond Special Assistant to the President and Director of Private Sector Engagement, President Barack Obama.
JOHN MARTIN Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.
Shannon Finley n/a
John D. Raffaelli n/a
David Jones n/a
Kyle Nevins n/a
Jim Gottleb n/a
Bradley Mollet n/a
Lyndon Boozer n/a
Martie Kendrick n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 22.
Original Filing: 301576198.xml
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54) and PBM reform including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 20.
Original Filing: 301533819.xml
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
3rd Quarter, 2023
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 19, 2023.
Original Filing: 301508458.xml
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
2nd Quarter, 2023
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301488477.xml
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Lobbying Issues
Monitoring legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
1st Quarter, 2023
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301466243.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management. Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 15, 2023.
Original Filing: 301427942.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2022
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405256.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2022
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 16, 2022.
Original Filing: 301381877.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2022
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 19, 2022.
Original Filing: 301360673.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2021
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 19, 2022.
Original Filing: 301329615.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2021
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301307521.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2021
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 19, 2021.
Original Filing: 301282590.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2021
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 19, 2021.
Original Filing: 301257883.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2020
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 20, 2021.
Original Filing: 301241328.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2020
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301220970.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2020
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 13, 2020.
Original Filing: 301187365.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2020
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 19, 2020.
Original Filing: 301172574.xml
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54). Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative and regulatory issues related to pharmacies. Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act. Coronavirus response efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2019
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 20, 2020.
Original Filing: 301122169.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2019
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 20, 2019.
Original Filing: 301072482.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2019
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 20, 2019.
Original Filing: 301053391.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2019
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 21, 2019.
Original Filing: 301032963.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2018
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 21, 2019.
Original Filing: 301011939.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2018
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 21, 2018.
Original Filing: 300993940.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2018
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on July 19, 2018.
Original Filing: 300969090.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2018
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on April 19, 2018.
Original Filing: 300952008.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2017
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on Jan. 19, 2018.
Original Filing: 300928967.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2017
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910963.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2017
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300889858.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2017
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on April 19, 2017.
Original Filing: 300871703.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2016
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on Jan. 17, 2017.
Original Filing: 300847730.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Legislative issues relating to the Supplemental Nutrition Assistance Program (SNAP) Retailer Eligibility Standards proposed rule.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2016
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on Oct. 20, 2016.
Original Filing: 300839936.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300812994.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on April 19, 2016.
Original Filing: 300794539.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $60,000. The report was filed on Jan. 19, 2016.
Original Filing: 300777628.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764840.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54); and Issues related to TRICARE in HR 1735, the National Defense authorization Act of FY2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 17, 2015.
Original Filing: 300738728.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 20, 2015.
Original Filing: 300724955.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation to Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 17, 2015.
Original Filing: 300699331.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Capitol Counsel, LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Oct. 17, 2014.
Original Filing: 300681126.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medication therapy management, including related legislation HR 1024 & S.557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on July 21, 2014.
Original Filing: 300667681.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
Capitol Counsel LLC amended a lobbying report for representation of Rite Aid Corporation in Q22014 on July 21, 2014.
Original Filing: 300669133.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on April 18, 2014.
Original Filing: 300641476.xml
Lobbying Issues
Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Capitol Counsel LLC lobbied for Rite Aid Corporation , earning $50,000. The report was filed on Jan. 21, 2014.
Original Filing: 300626873.xml
Lobbying Issues
Prescription drug track and trace legislation, including related provisions in H.R. 3204, the Drug Quality and Security Act; Monitor implementation issues related to the Affordable Care Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medication therapy management, including HR 1024 & S 557, the Medication Therapy Management Empowerment Act, and monitor S. 1871, SGR Repeal and Medicare Beneficiary Access Act and HR 2810 Medicare Patient Access and Quality Improvement Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
Capitol Counsel LLC filed a lobbying registration on Dec. 17, 2013 to represent Rite Aid Corporation, effective Nov. 1, 2013.
Original Filing: 300610573.xml
Issue(s) they said they’d lobby about: Medication therapy management, including related legislation HR 1024 & S 557, the Medication Therapy Management Empowerment Act; Medicaid prescription drug reimbursement, including implementation of related provisions in the Patient Protection and Affordable Care Act (P.L. 111-148/P.L. 111-152); and Prescription drug track and trace legislation, including implementation of related provisions in the Drug Quality and Security Act (P.L. 113-54) .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...